MEDICA 2025: Matchmaking with Taiwanese Medical Innovators

🌍 UBIK is hosting for the second time a hybrid matchmaking meeting (onsite + online) to connect Taiwanese medical innovators with European partners at MEDICA 2025!

Seven cutting-edge Taiwanese companies from the medical and healthcare sector will be exhibiting. Ahead of the fair, UBIK is organising online B2B meetings (20–23 October 2025) to help you connect in advance.

Each meeting lasts 45 minutes, a unique chance to explore cooperation in medical devices, biotechnology, digital health, and healthcare solutions.

European companies attending MEDICA, or interested in joining online, are warmly invited!

👉 Sign up here: https://forms.gle/JQ4GtCQaqABsnbCD7

💵 Fee: Free of charge

📅 Online Matchmaking dates:  20–23 October 2025 (~45 minutes meeting)

⏳ Deadline: 15 September 2025

Meet the Taiwanese Innovators:

• AeproMED – Specializing in lung & breathing solutions. Their flagship product, AniFree™, is an anesthesia-free aerosol chamber, and NEBreath™ is designed for asthma and COPD patients.

More details

AeproMED's AIRHYPER One-Stop Inhalation Drug Development Platform offers a quick therapeutic onset while minimizing systemic side effects. Leveraging professional aerosol science, it ensures precise drug-aerosol delivery directly to the lungs. This versatile technology supports animal pre-clinical trials, supportive therapies, and lung disease treatment. Designed with a user-centric approach, it integrates seamlessly with respiratory medicine for chronic disease management. Additionally, it provides cutting-edge technology for developing new compounds to treat cancer or for supportive therapies in sub-healthy conditions. AeproMED's platform is a significant advancement in the medical and healthcare fields, aiming to cooperate with pharmaceutical and biotech companies to explore new applications of inhalation therapy and benefit more patients.

• BioPro Scientific – Neurology-focused medical devices. Products like Lilia Neuro and Lilia Stim offer earphone-like personalized brain stimulation tools, while NeuLive provides wireless amplifiers/stimulators for animal and human research.

More details

The company specializes in translating neuroscience research into practical medical applications. BioPro Scientific has developed state-of-the-art neuroscience tools and pioneered brainwave-based early detection methods for Parkinson's disease. The company has also advanced novel approaches to neurostimulation therapy, contributing to innovations in neurological treatment.

BioPro Scientific's core focus is making brain health technologies accessible, with the goal of enabling individuals to monitor and maintain their mental well-being.

• EndoSemio – Next-generation human & veterinary endoscopy solutions, including AI-powered ENT and neonatal scopes.

More details

EndoSemio is the pioneer of single-use endoscopes. At EndoSemio, we make products that directly meet the needs of healthcare professionals. Guided by the demands of clinical practitioners, our development process is grounded in a commitment to meeting their precise requirements. Simultaneously, we possess a distinctive proficiency in harmoniously merging the intricate aspects of imaging modules, effectively encapsulating both software and hardware elements into a cohesive whole. Our product lineup includes innovative wireless endoscope imaging tracheostomy kit, neonatal and pediatric respiratory imaging catheters, and single-use flexible ureteroscopes.

• FaceHeart – FDA-cleared AI software for video-based vital signs monitoring, measuring heart rate, respiration, and more via a standard camera.

More details

Introducing FaceHeart Vitals™

FaceHeart Vitals™ is a cutting-edge, FDA-cleared software solution for video-based vital signs monitoring. It allows users to measure, display, and record real-time vital sign data in 50 seconds—all through a standard RGB camera.

With FaceHeart Vitals™, users can effortlessly check their health anytime, anywhere—whether at home, at work, or on the move. Simply look into a camera-equipped device to receive a comprehensive report featuring six vital signs and six health indicators, including heart rate, blood pressure, respiratory rate and SpO2.

Powered by Advanced AI and Image Processing

Our technology leverages cutting-edge facial recognition, remote photoplethysmography (rPPG), and real-time image analysis, offering a contactless and highly flexible health monitoring experience. Delivered through a Software Development Kit (SDK), FaceHeart’s solution can be integrated into any video-capable device—such as smartphones, tablets, mirrors, and medical terminals—empowering partners across multiple industries.

FaceHeart Vitals™ has received:

1.FDA 510(k) clearance (K223622) for vital signs monitoring in September 2023

2.FDA 510(k) clearance (K243966) for respiratory monitoring in April 2025

• Neurobit – AI-driven eye-tracking systems for neuro-vestibular diagnostics, dizziness screening, and childhood myopia prevention.

More details

Neurobit is a biomedical innovation company building intelligent healthcare platforms based on visual physiological signals. By integrating eye movement data, optical measurements, and AI analytics, we develop solutions for clinical decision support, health risk prediction, and patient-centered care.

Our technologies range from neurological and vestibular diagnostics to myopia risk tracking in children, and are certified for medical use across multiple regions. Our products are trusted by specialists in neurology, ophthalmology, ENT, family medicine, and preventive healthcare.

• PROVIEW-MBD Biotech – Developer of ThergiSpray, a synthetic polymer hydrogel for post-surgical adhesion prevention.

More details

ThergiSpray is specifically designed to prevent or reduce adhesion formation following open, conservative, or minimally invasive surgeries in the abdominopelvic area.

Key Points

* Bioresorbable thermosensitive polymer hydrogel pecifically formulated for spray application

* Purpose-built applicator designed for precise and convenient intraoperative use

* Sterile, non-pyrogenic, single-use formulation with a distinct blue color for easy visual identification during surgery

* Remains liquid at low temperatures and transitions into a solid gel upon contact with body temperature

* Delivers an even spray coating on peritoneal surfaces, forming a temporary barrier that interrupts adhesion formation and reduces its severity

• S&T Biomed – Innovator in oral cancer diagnostics, with biomarker-based ELISA kits and rapid strip tests for early detection.

More details

(1) EarlyFound® MMP-1 ELISA kit

-Quantitative data (concentration)

-Easy performed in clinical lab

-Suitable for high throughput test

-Validation in 1,031 saliva specimens

-Sensitivity: 85.6% (95% CI: 81.4–89.0%)

-Specificity: 78.7% (95% CI: 75.5–81.6%)

-Accuracy: 80.9% (95% CI: 78.4–83.2%)

-Use scenario：Utilized with ELISA reader equipment within hospitals for the auxiliary diagnosis of oral cancer and for monitoring the prognosis of oral cancer.

-Obtained medical device approvals from CE (IVDD), Singapore HSA, Australia TGA, Hong Kong MDD, Thailand FDA, and Vietnam MoH.

(2) EarlyFound® MMP-1 Rapid Strip Test

-Qualitative data

-Easy performed by oneself

-Suitable for point-of-care test

-Validation in 1,029 saliva specimens

-Sensitivity: 79.8% (95% CI: 75.1–83.8%)

-Specificity: 86.2% (95% CI: 83.5–85.6%)

-Accuracy: 84.2% (95% CI: 81.8–86.3%)

-Use scenario：For first-line oral cancer screening and suitable for use in out-of-hospital settings.

-Obtained medical device approval under CE (IVDD); registration reviews are currently in progress with Singapore HSA, Australia TGA, and Hong Kong MDD.

📩Contact: Lys Attimont - Project Manager - lys.attimont@ubik.com.tw